University Home | Hospital | Pulse Employment | Contact Us | Search | News 
Thomas Jefferson University Search Jefferson
Jefferson Medical College Jefferson College of Graduate Studies Jefferson College of Health Professions
Menu

Thomas Jefferson University - Judith L. Ross
Judith L. Ross

Pediatrics
Thomas Jefferson University
Jefferson Medical College
Department of Pediatrics
Professor Appointed: 1992

Thomas Jefferson University
Jefferson Medical College
Department of Pediatrics
Division of Pediatric Endocrinology
Chief Appointed: 1992

Mailing Address
1025 Walnut Street
Philadelphia, Pennsylvania 19107
United States
Contact Information
Phone: (215) 955-1648
judith.ross@jefferson.edu
Qualifications
Board Certification, Pediatric Endocrinology, 1983

Board Certification, American Academy of Pediatrics, 1982

Medical Licensure, New Jersey and Pennsylvania,

B.A. with High Honors, Wellesley College, 1972

M.D., University of Chicago, Pritzker School of Medicine, 1977

Expertise and Research Interests

Estrogen and androgen appear to influence brain function in females atpuberty. Environmental and cultural factors interact with the biologicaleffects of estrogen and androgen on he brain an consequently on cognitionand behavior. Women with Turner syndrome have dysgenetic ovaries thatdo not produce estrogen or androgen, before or at puberty. Therefore, Turner syndrome represents a unique, sex hormone-deficient, model inwhich to study the biological effects of androgen on cognition andbehavior. The overall goal of this project is to study design we willstudy 1 two Turner syndrome groups: A androgen and B no androgenand 2 an age-matched, normal female control group. The specific aimsof this project are to: 1 examine the effects of androgen on cognitiveand social function in adolescent 11-13 years, growth hormone-treatedgirls with Turner syndrome, and 2 documented the differences andsimilarities in cognitive and behavioral function between adolescentTurner syndrome girls treated or not treated wit androgen and age-andVIQ-girls treated with androgen, or not androgen-treated: 1 Turnersyndrome girls treated with androgen versus no androgen will performbetter on the tests of visual-spatial ability and visual-motor ability, 2 Turner syndrome girls treated with androgen versus no androgen willnot perform differently on tests of attention, executive function, socialfunction, and affective competence, 3 Turner girls treated withandrogen for 2 years will demonstrate the greatest treatment effects, compared to girls treated for 1 year, and 4 androgen treatment willsignificantly reduce the differences between Turner syndrome and normalcontrols girls on tests executive function, social function, andaffective competence. This investigation of adolescent cognitive and social development is animportant step in understanding normal brain development. In addition, these data will determine how to optimize cognitive function in Turnersyndrome, and will extend knowledge of the underlying mechanisms ofsexual dimorphism.

Estrogen influences brain development in females at puberty. Environmental and cultural factors interact with the biological effects ofestrogen on the brain and consequently on cognition and behavior. Womenwith Turner syndrome lack endogenous estrogen as a result of dysgeneticovaries. Turner syndrome, therefore, represents a unique, estrogen- deficient model in which to study the biological effects of estrogen oncognition and behavior. The specific aims of this project are to: 1 toexamine the differential effects of continuous estrogen replacement inearly childhood on cognitive and social function in an ongoing, unique, randomized, double-blind, placebo-controlled, treatment trial. 2 documentfurther, the cognitive differences between girls with Turner syndrome atages 8 and 12 years versus age-matched, normal girls. Specifically, wehypothesize that estrogen replacement in early childhood will reduce thecognitive deficits of girls with Turner syndrome. In addition, wehypothesize that earlier age 5-7 years and longer estrogen replacementwill result in less impairment of visual-spacial ability, visual-motorability, social function, and affective competence compared to later 9 to12 years estrogen replacement in girls with Turner syndrome. Finally, wehypothesize that the degree of social function in these girls willcorrelate with visual-spatial ability and facial recognition ability. The data generated from this carefully controlled biological investigationof cognitive and social development is an important stage in understandingnormal brain development. In addition, these data will help determine howto optimize cognitive function in Turner syndrome, and will extendknowledge of the underlying mechanisms of sexual dimorphism.
Other Expertise

OTHER APPOINTMENTS (1997-present)
1983-present Adjunct Scientist, National Institute of Child Health and Human Development.

REVIEWER
Ad hoc reviewer for NIH study section: Human Development and Aging, Subcommittee 3;
Journal of Clinical Endocrinology and Metabolism, Clinical Pediatrics,Pediatric Research,Pediatrics,and Diabetes.

POSITIONS IN PROFESSIONAL SOCIETIES (1997-present)
1995 - present Board of Directors, Phila. Endocrine Society;
1996 - present Council, Eastern Society for Pediatric Research.

ABSTRACTS (1997-present):
Ross, J.L. Symposium: Cognitive function in Turner syndrome: hormonal, genetic and learning disability perspectives, presented at The 25th Annual Meeting of the International Neuropsychological Society, Orlando, FL, February, 1997;
Ross, J.L. Symposium: Gonadal steroids and the brain, Estrogen effects on motor and neurocognitive development, presented at The Endocrine Society Meeting, Minneapolis, MN, June 14, 1997;
Roeltgen D., Ross J.L. Faster nonverbal processing speed in adolescent girls with Turner syndrome (TS) treated with estrogen, presented at the American Academy of Neurology Meeting, Minneapolis, MN, April 27, 1998;
Ross, J.L., Feuillan, P., Kowal, K., Guthrie, L., Bernstein, L., Troendle, J., and Cutler, G.B., Jr. Combined estrogen and growth hormone treatment increases bone density of the spine in girls with Turner syndrome, presented at The Endocrine Society Meeting, New Orleans, LA, June 27, 1998;
Ross, J.L., Roeltgen, D., Zinn, A. The hallmark cognitive deficit associated with Turner syndrome maps to the short arm of the X chromosome, presented at the 51st Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 21, 1999;
Mazzocco, M.M.M., Abrams, M.T., Whitley, J.A., Ross, J.L., Kaufmann, W.E., Denckla, M.B. Specificity of the neurodevelopmental effects of Turner syndrome, Archives of Clinical Neuropsychology, National Academy of Neuropsychology, San Antonio, TX, 1999;
Ross, J.L., Kushner, H., Zinn, A. The Turner syndrome-associated neurocognitive phenotype maps to distal Xp, presented at the American Society of Human Genetics Meeting, San Francisco, CA, October 19-23, 1999;
Zinn, A.R., Prueitt, R.L., Papenhausen, P.R., Roberts, V.L., and Ross, J.L. Short stature and premature ovarian failure loci in proximal Xp, presented at the American Society of Human Genetics Meeting, San Francisco, CA, October 19-23, 1999;
Prueitt, R.L., Ross, J.L., and Zinn, A.R. Identification of a premature ovarian failure candidate gene, presented at the American Society of Human Genetics Meeting, San Francisco, CA, October 19-23, 1999;
Zinn, A.R., Osterman, A.L., Scott, C.I., Jr., Nicholson, L., Ross, J.L. Relationship of Madelung's deformity to Leri-Weill syndrome and ShOX mutations, presented at the American Society of Human Genetics Meeting, Philadelphia, PA, October 3-7, 2000;
Wei, F., Chheng, S., Elder, F.F.B., Scott, C.I., Jr., Nicholson, L., Ross, J.L., Zinn, A.R. A man who inherited SRY and Leri-Weill dyschondrosteosis from his mother and neurofibromatosis from his father, presented at the American Society of Human Genetics Meeting, Philadelphia, PA, October 3-7, 2000;
Ross, J.L., Russell, H.F., Power, T.J., Mazzocco, M.M., Zinn, A., Muenke, M. Evidence against imprinting effects on cognition in Turner syndrome, presented at the American Society of Human Genetics Meeting, Philadelphia, PA, October 3-7, 2000;
Roeltgen, D., Ross, J.L. Role of estrogen deficiency in cognitive function of women with premature ovarian failure, presented at the 53rd American Academy of Neurology Annual Meeting, Philadelphia, PA, May 5-11, 2001.

SPEAKING ENGAGEMENTS (1997-present)
Congenital adrenal hyperplasia and prococious puberty, Visiting Professor, Susquehanna Health System, Williamsport, PA, Jan 24, 1997;
Neonatal hyperthyroidism, Perinatal Conference, Lankanau Hospital, March 5, 1997;
Aspects of Turner syndrome, Conference of Philadelphia Turner syndrome Society, Lankanau Hospital, April 27, 1997;
Hypothyroidism: congenital and juvenile. Pediatric Grand Rounds, Bryn Mawr Hospital, May 2
Keywords
Adolescence; Androgen; Attention; Child Psychology; Clinical Trial; Cognition; Cognition Disorder; Cognitive Behavior Therapy; Estrogen; Female; Hormone Therapy; Human Puberty; Human Subject; Human Therapy Evaluation; Intelligence Test; Interview; Longitudinal Human Study; Memory; Middle Childhood; Nervous System; Neurological Disorders; Neuropsychological Test; Oxandrolone; Placebo; Questionnaire; Self Concept; Social Behavior; Somatotropin; Space Perception; Stroke; Turner'S Syndrome; Verbal Learning; Visual Perception
Publications
  • Wei F, Cheng S, Badie N, Elder F, Scott C Jr, Nicholson L, Ross JL, Zinn AR. A man who inherited his SRY gene and Leri-Weill dyschondrosteosis from his mother and neurofibromatosis type 1 from his father. American Journal of Medical Genetics. 102(4): 353-8, 2001

  • Zinn AR, Ross JL. Molecular analysis of genes on Xp controlling Turner syndrome and premature ovarian failure (POF). Seminars in reproductive medicine. 19: 141-146, 2001

  • Ross JL; Roeltgen D; Feuillan P; Kushner H; Cutler GB Jr. Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology. 54(1): 164-70, 11 2000

  • Ross JL, Roeltgen D, Kushner H, Wei F, Zinn AR. The Turner syndrome-associated neurocognitive phenotype maps to distal Xp. American Journal of Human Genetics. 67(3): 672-81, Sep 2000

  • Zinn, A.R. and Ross, J.L. Critical regions for Turner syndrome phenotypes on the X chromosome. In: Proceedings of the 5th International Turner Symposium: Optimizing Health Care for Turner Patients in the 21st Century, Elsevier Science B.V., Amsterdam, the Netherlands. 19-28, 2000

  • Ross J, Zinn A, McCauley E. Neurodevelopmental and psychosocial aspects of Turner syndrome. Mental Retardation and Developmental Disabilities Research Reviews. 6(2): 135-41, 2000

  • Prueitt RL, Ross JL, Zinn AR. Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenetics and Cell Genetics. 89(1-2): 44-50, 2000

  • Ross, J.L. and Zinn, A. Turner syndrome: Potential hormonal and genetic influences on the neurocognitive profile. In: Neurodevelopmental Disorders: Contributions to a New Framework from the Cognitive Neurosciences,Tager-Flusberg,H.(ed), MIT Press, Boston, Mass. 251-268, 1999

  • Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, Kushner H, Schwartz S, Sybert VP, Van Dyke DL, Ross JL. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. American Journal of Human Genetics. 63(6): 1757-66, Dec 1998

  • Romans SM; Stefanatos G; Roeltgen DP; Kushner H; Ross JL. Transition to young adulthood in Ullrich-Turner syndrome: neurodevelopmental changes. American Journal of Medical Genetics. 79(2): 140-7, 1 Sep 1998

  • Ross J L;Roeltgen D;Feuillan P;Kushner H;Cutler G B Jr. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. Journal of Clinical Endocrinology and Metabolism. 83(9): 3198-204, Sep 1998

  • Zinn AR, Ross JL. Turner syndrome and haploinsufficiency. Current Opinion in Genetics and Development. 8(3): 322-7, Jun 1998

  • Ross JL; Feuillan P; Kushner H; Roeltgen D; Cutler GB Jr. Absence of growth hormone effects on cognitive function in girls with Turner syndrome [see comments. Journal of Clinical Endocrinology and Metabolism. 82(6): 1814-7, 1997

  • Blatt J, Olshan AF, Lee PA, Ross JL. Neuroblastoma and related tumors in Turner's syndrome. Journal of Pediatrics. 131(5): 666-70, Nov 1997

  • Ross J L;Kushner H;Zinn A R. Discriminant analysis of the Ullrich-Turner syndrome neurocognitive profile. American Journal of Medical Genetics. 72(3): 275-80, 31 Oct 1997

  • Zinn A R;Ouyang B;Ross J L;Varma S;Bourgeois M;Tonk V. Del (X)(p21.2) in a mother and two daughters with variable ovarian function. Clinical Genetics. 52(4): 235-9, Oct 1997

  • Zinn AR; Ouyang B; Ross JL; Varma S; Bourgeois M; Tonk V. Del \(X\)\(p21.2\) in a mother and two daughters with variable ovarian function. Clinical Genetics. 52(4): 235-9, Oct 1997

  • Chalom EC, Ross J, Athreya BH. Syndromes and arthritis. Rheumatic Diseases Clinics of North America. 23(3): 709-27, Aug 1997

  • Ross J L;Feuillan P;Kushner H;Roeltgen D;Cutler G B Jr. Absence of growth hormone effects on cognitive function in girls with Turner syndrome. Journal of Clinical Endocrinology and Metabolism. 82(6): 1814-7, Jun 1997

  • Romans SM, Roeltgen DP, Kushner H, and Ross JL. Executive function in females with Turner syndrome. Developmental Neuropsychology. 13: 23-40, 1997

  • Ross J L;Kushner H;Roeltgen D P. Developmental changes in motor function in girls with Turner syndrome. Pediatric Neurology. 15(4): 317-22, Nov 1996

  • Reiss A L;Abrams M T;Singer H S;Ross J L;Denckla M B. Brain development, gender and IQ in children. A volumetric imaging study. Brain. 119 ( Pt 5): 1763-74, Oct 1996

  • Ross J L;McCauley E;Roeltgen D;Long L;Kushner H;Feuillan P;Cutler G B Jr. Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects. Journal of Clinical Endocrinology and Metabolism. 81(3): 926-31, Mar 1996

  • Ross, J.L. Disorders of the adrenal in the newborn. In: Intensive Care of the Fetus and Neonate, Spitzer, A.(ed), Mosby,St. Louis. 970-981, 1996

  • Reiss A L;Mazzocco M M;Greenlaw R;Freund L S;Ross J L. Neurodevelopmental effects of X monosomy: a volumetric imaging study. Annals of Neurology. 38(5): 731-8, Nov 1995

  • Ross J L;Stefanatos G;Roeltgen D;Kushner H;Cutler G B Jr. Ullrich-Turner syndrome: neurodevelopmental changes from childhood through adolescence. American Journal of Medical Genetics. 58(1): 74-82, 31 Jul 1995

  • McCauley E;Ross J L;Kushner H;Cutler G Jr. Self-esteem and behavior in girls with Turner syndrome [published erratum appears in J Dev Behav Pediatr 1995 Jun;16(3):210]. Journal of Developmental and Behavioral Pediatrics. 16(2): 82-8, Apr 1995

  • Feuillan P P;Jones J;Ross J L. Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. Journal of Clinical Endocrinology and Metabolism. 80(4): 1357-60, Apr 1995

  • Ross J L;Feuillan P;Long L M;Kowal K;Kushner H;Cutler G B Jr. Lipid abnormalities in Turner syndrome. Journal of Pediatrics. 126(2): 242-5, Feb 1995

  • Ross, J.L. Estrogen therapy in the treatment of Turner syndrome. In: Turners Syndrome Across the Life Span, Rovet, J. (ed), Klein Graphics, Markham, Ontario. 93-97, 1995

  • Ross, J.L., Roeltgen D, and Cutler, GB, Jr. The neurodevelopmental transition between childhood and adolescence. In: Turner Syndrome in a Life Span Perspective: Research and Clinical Aspects, Elsevier Science Publishers B.V., Amsterdam, Netherlands. 297-308, 1995

  • Johnson, R. Jr. and Ross, J.L. Electrophysiological indications of altered brain development in patients with Turner's syndrome: an event-related potential study. In: Atypical cognitive deficits in developmental disorders: implications for brain function. Hillsdale, NJ, Lawrence Erlbaum Assoc., Inc. Publishers. 217-244, 1994

  • McCauley, E., Ross, J., and Sybert, V. Self-concept and behavioral profiles in Turner syndrome. In: Growth, Stature, and Adaptation: Behavioral, Social, and Cognitive Aspects of Growth Delay, Chapel Hill, NC, Univ. of North Carolina Press. 181-193, 1994

  • Ross JL, Long LM, Marin G, Rose SR, Feuillan P, and Cutler GB Jr. Pubertal changes in bone mineral content of the wrist and spine in normal boys and girls. Clinical Pediatric Endocrinology. 3: 55-62, 1994

  • Johnson R, Rohrbaugh JW, Ross JL. Altered brain development in Turner's syndrome: an event-related potential study. Neurology. 43(4): 801-8, Apr 1993

  • Ross, J.L. Short stature. In: Current Pediatric Therapy. W. B. Saunders Company, Phila. , 1993

  • Ross, J.L., Reiss, A., Freund, L., Roeltgen, D. and Cutler, G.B. Estrogen effects on cognition and social function in Turner syndrome. In: Excerpta Medica International Congress Series, Elsevier Science Publishers B.V., Amsterdam, Netherlands. 215-223, 1993

  • Ross J L;Reiss A L;Freund L;Roeltgen D;Cutler G B Jr. Neurocognitive function and brain imaging in Turner syndrome--preliminary results. Hormone Research. 39 Suppl 2: 65-9, 1993

  • Cutler G B Jr;Ross J L. Estrogen therapy in Turner's syndrome. Acta Paediatrica Japonica. 34(2): 195-202; discussion, Apr 1992

  • Ross JL and Cutler GB Jr. The optimal use of estrogen in the treatment of Turner syndrome. The Endocrinologist. 2: 119-121, 1992

  • Ross J L;Long L M;Feuillan P;Cassorla F;Cutler G B Jr. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. Journal of Clinical Endocrinology and Metabolism. 73(2): 355-9, Aug 1991

  • Rose S R;Municchi G;Barnes K M;Kamp G A;Uriarte M M;Ross J L;Cassorla F;Cutler G B Jr. Spontaneous growth hormone secretion increases during puberty in normal girls and boys. Journal of Clinical Endocrinology and Metabolism. 73(2): 428-35, Aug 1991

  • Namba H, Ross JL, Goodman D, Fagin JA. Solitary polyclonal autonomous thyroid nodule: a rare cause of childhood hyperthyroidism. Journal of Clinical Endocrinology and Metabolism. 72(5): 1108-12, May 1991

  • Cutler, G.B., Jr., Ross, J.L., Rose, S.R. Are girls with Turner syndrome growth hormone-deficient?. In Rosenfeld, R.G. and Grumbach, M.M. (eds): Turner Syndrome, New York, Marcel Dekker Publishers. 227-32, 1990

  • Ross, J.L., Cutler, G.B., Jr. Estrogen therapy in Turner syndrome. In: Rosenfeld, R.G. and Grumbach, M.M. (eds): Turner Syndrome, New York, Marcel Dekker Publishers. 361-369, 1990

  • Ross, J.L. Disorders of the sex chromosomes: medical overview. In: Holmes, C.S. (ed):Psychoneuroendocrinology.New York, Springer Verlag Publisher. 127-138, 1990

  • Johnson, R., Jr., Rohrbaugh J.W., Ross J.L. Event-related potential reactivity in patients with Turner's syndrome. In: Psychological Brain Research, Eds. Brunia C.H.M., Gaillard, A.W.K., Kokia, Tilburg Univ. Press. 180-183, 1990

  • Cronk .E, Stalling VA, Spender QW, Ross JL, and Widdoes HD. Measurement of short-term growth with a new knee height measuring device. American Journal of Human Biology. 1: 421-428, 1989

  • Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler GB. The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. New England Journal of Medicine. 319(4): 201-7, 1988

  • Ross JL, Cassorla F, Carpenter G, Long LM, Royster MS, Loriaux DL, Cutler GB. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome. Journal of Clinical Endocrinology and Metabolism. 67(3): 515-8, Sep 1988

  • Laue L, Hoeg JM, Barnes K, Ross JL, Loriaux DL, Chrousos GP. Abnormal growth hormone secretory dynamics in children with familial hypercholesterolemia. Hormone Research. 29(1): 23-6, 1988

  • Rose S.R, Kibarian M, Gelato M, Ross JL, Muellner J, Gay K, Cutler GB Jr, Cassorla F. Sex steroids increase spontaneous growth hormone secretion in short children. Journal of Pediatric Endocrinology. 3: 1-5, 1988

  • Ross, J.L., Cassorla, F.G., Long, L.M., Skerda, M., Caruso- Nicoletti, M., Malozowski, S., Rose, S.R., Barnes, K.M., Loriaux, D.L., Cutler, G.B., Jr. Mechanism of the pubertal growth spurt. In Grave G.D. and Cassorla G.G.(eds):Disorders of Human Growth: Advances in Research and Treatment.Springfield, IL, Charles Thomas Co. 299-305, 1988

  • Rose, S.R., Ross, J.L., Uriarte, M., Barnes, K.M., Cassorla, F.G., Cutler, G.B., Jr. Spontaneous growth hormone secretion in normal and short prepubertal children. In: Grave G.D. and Cassorla G.G.(eds):Disorders of Human Growth: Advances in Research and Treatment.Springfield, IL, Charles Thomas Co. 144-157, 1988

  • Cronk, C.E., Stalling, V.A., Ross, J.L. Measurement of short term growth in children with Crohn's disease. In: Inflammatory Bowel Disease: current status and future approach. Elsevier Science Publishers B.V. (Biomedical Division). 677-682, 1988

  • Ross JL, Pescovitz OH, Barnes K, Loriaux DL, Cutler GB. Growth hormone secretory dynamics in children with precocious puberty. Journal of Pediatrics. 110(3): 369-72, Mar 1987

  • Cutler, G.B., Jr., Barnes, K.M., Loriaux, D.L., Ross, J.L. Developmental changes in gonadotropin secretion in Turner syndrome. In: Crowley, W.F., Jr. and Hofler, J.G. (eds):The Edisodic Secretion of Hormones. New York, Wiley. 201-215, 1987

  • Cutler, G.B., Jr., Ross, J.L. Turner syndrome: therapeutic options. In Preece, M.A. (ed): International Symposium on Growth Disorders, Princeton, NJ, Excerpta Medica/An Elsevier Company. 31-39, 1987

  • Ross JL, Long LM, Skerda M, Cassorla F, Kurtz D, Loriaux DL, Cutler GB. Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome. Journal of Pediatrics. 109(6): 950-3, Dec 1986

  • Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, Loriaux DL, Cassorla F, Merriam GR. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency. Journal of Clinical Endocrinology and Metabolism. 63(1): 174-9, Jul 1986

  • Shawker TH, Garra BS, Loriaux DL, Cutler GB, Ross JL. Ultrasonography of Turner's syndrome. Journal of Ultrasound in Medicine. 5(3): 125-9, Mar 1986

  • Ross JL, Schulte HM, Gallucci WT, Cutler GB, Loriaux DL, Chrousos GP. Ovine corticotropin-releasing hormone stimulation test in normal children. Journal of Clinical Endocrinology and Metabolism. 62(2): 390-2, Feb 1986

  • Cutler GB, Cassorla FG, Ross JL, Pescovitz OH, Barnes KM, Comite F, Feuillan PP, Laue L, Foster CM, Kenigsberg D. Pubertal growth: physiology and pathophysiology. Recent Progress in Hormone Research. 42: 443-70, 1986

  • Ross JL, Long LM, Skerda M, Cassorla F, Loriaux DL, Cutler GB Jr. Growth response relationship between growth hormone dose and short term growth in patients with Turner syndrome. Journal of Clinical Endocrinology and Metabolism. 63: 1028-1030, 1986

  • Caruso-Nicoletti M, Cassorla F, Skerda M, Ross JL, Loriaux DL, Cutler GB. Short term, low dose estradiol accelerates ulnar growth in boys. Journal of Clinical Endocrinology and Metabolism. 61(5): 896-8, Nov 1985

  • Gelato MC, Ross JL, Malozowski S, Pescovitz OH, Skerda M, Cassorla F, Loriaux DL, Merriam GR. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency. Journal of Clinical Endocrinology and Metabolism. 61(3): 444-50, Sep 1985

  • Ross JL, Long LM, Loriaux DL, Cutler GB. Growth hormone secretory dynamics in Turner syndrome. Journal of Pediatrics. 106(2): 202-6, Feb 1985

  • Ross JL, Cutler GB Jr. Turner Syndrome (Letter). Journal of Pediatrics. 107: 642, 1985

  • Ross JL, Barnes KM, Brody S, Merriam GR, Loriaux DL, Cutler GB. A comparison of two methods for detecting hormone peaks: the effect of sampling interval on gonadotropin peak frequency. Journal of Clinical Endocrinology and Metabolism. 59(6): 1159-63, Dec 1984

  • Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism. 59(4): 801-5, Oct 1984

  • Chrousos GA, Ross JL, Chrousos G, Chu FC, Kenigsberg D, Cutler G, Loriaux DL. Ocular findings in Turner syndrome. A prospective study. Ophthalmology. 91(8): 926-8, Aug 1984

  • Foster CM, Ross JL, Shawker T, Pescovitz OH, Loriaux DL, Cutler GB, Comite F. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism. 58(6): 1161-5, Jun 1984

  • Ross JL, Cassorla FG, Skerda MC, Valk IM, Loriaux DL, Cutler GB. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. New England Journal of Medicine. 309(18): 1104-6, 1983

  • Levine JA, Loriaux D.L, Cutler GB Jr. Developmental changes in neuroendocrine regulation of gonadotropin secretion in Turner's syndrome. Journal of Clinical Endocrinology and Metabolism. 57: 288-292, 1983

  • Levine J, Wolfe LG, Schiebinger RJ, Loriaux DL, Cutler GB. Rapid regression of fetal adrenal zone and absence of adrenal reticular zone in the marmoset. Endocrinology. 111(6): 1797-802, Dec 1982

  • Cutler G Jr, Schiebinger R, Albertson B, Cassorla F, Chrousos G, Comite F, Booth J, Levine J, Hobson W, Loriaux DL. The Adrenarche (Human and Animal). In: M.M. Grumbach and P.C. Sizonenko (Eds.), Proceedings of the Second International Conference on the Control of the Onset of Puberty Academic Press, NY. , 1981

  • Levine J, Honig PJ, Boyle T. Salmonella reactive arthritis: clues to diagnosis. Journal of Pediatrics. 94(4): 596-7, Apr 1979

  • Kieff E, Levine J. Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis. Proceedings of the National Academy of Sciences (USA). 71(2): 355-8, Feb 1974

Individual Expertise profile of Judith L. Ross, Copyright © Judith L. Ross.
Last Updated :



Maintained by Thomas Scozzare
Copyright © Thomas Jefferson University. All Rights Reserved.

 Printable Version

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement.
Thomas Jefferson University
Farber Institute for Neurosciences